Centene (NYSE:CNC) Price Target Raised to $39.00

Centene (NYSE:CNC) had its price target increased by stock analysts at Deutsche Bank Aktiengesellschaft from $32.00 to $39.00 in a research note issued to investors on Tuesday,MarketScreener reports. The brokerage presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 1.79% from the company’s current price.

Other equities analysts have also recently issued reports about the company. Wells Fargo & Company set a $43.00 price objective on Centene and gave the company an “equal weight” rating in a report on Wednesday, January 7th. Mizuho set a $47.00 target price on Centene in a research report on Friday, January 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a report on Wednesday, January 21st. Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Centene in a research report on Friday, October 31st. Three investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $41.25.

Centene Price Performance

Shares of CNC opened at $38.32 on Tuesday. The firm has a market cap of $18.83 billion, a PE ratio of -2.79, a price-to-earnings-growth ratio of 0.88 and a beta of 0.48. Centene has a 52-week low of $25.08 and a 52-week high of $66.03. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.08 and a current ratio of 1.10. The business’s 50 day moving average price is $42.03 and its two-hundred day moving average price is $36.07.

Centene (NYSE:CNC) last issued its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business had revenue of $49.73 billion for the quarter, compared to analysts’ expectations of $48.41 billion. During the same period last year, the business earned $0.80 EPS. The business’s revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, equities analysts anticipate that Centene will post 6.86 EPS for the current year.

Hedge Funds Weigh In On Centene

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Addison Advisors LLC boosted its holdings in Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after acquiring an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Centene in the third quarter worth about $27,000. SBI Securities Co. Ltd. increased its stake in shares of Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after acquiring an additional 406 shares during the period. WPG Advisers LLC lifted its holdings in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares during the period. Finally, Bogart Wealth LLC grew its position in shares of Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after acquiring an additional 991 shares during the period. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.